Jaguar Health Inc (NASDAQ:JAGX)’s share price was down 18.2% on Thursday . The company traded as low as $0.27 and last traded at $0.27. Approximately 1,409,769 shares changed hands during mid-day trading, an increase of 78% from the average daily volume of 793,853 shares. The stock had previously closed at $0.33.
Separately, ValuEngine upgraded Jaguar Health from a “hold” rating to a “buy” rating in a report on Thursday, November 1st.
The company has a debt-to-equity ratio of 1.03, a current ratio of 0.46 and a quick ratio of 0.31.
Jaguar Health (NASDAQ:JAGX) last released its earnings results on Monday, November 19th. The biotechnology company reported ($0.61) EPS for the quarter. The business had revenue of $1.13 million for the quarter. Jaguar Health had a negative net margin of 908.28% and a negative return on equity of 259.67%.
COPYRIGHT VIOLATION WARNING: “Jaguar Health (JAGX) Stock Price Down 18.2%” was originally reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://www.thelincolnianonline.com/2019/01/12/jaguar-health-jagx-stock-price-down-18-2.html.
Jaguar Health Company Profile (NASDAQ:JAGX)
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Featured Article: What are defining characteristics of a correction?
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.